Skip to Content

W P97 (Primaquine Phosphate 26.3 mg (15 mg base))

Pill with imprint W P97 is Pink, Round and has been identified as Primaquine Phosphate 26.3 mg (15 mg base). It is supplied by Sanofi-Aventis.

Primaquine is used in the treatment of pneumocystis pneumonia; malaria prevention; malaria and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 26.3 mg (15 mg base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for W P97

Primaquine phosphate 26.3 mg (15 mg base) W P97
Primaquine phosphate 26.3 mg (15 mg base) W P97
Primaquine phosphate 26.3 mg (15 mg base) W P97

Primaquine Phosphate

Imprint
W P97
Strength
26.3 mg (15 mg base)
Color
Pink
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimalarial quinolines
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sanofi-Aventis
Inactive Ingredients
carnauba wax, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, polysorbate 80, ferric oxide red, magnesium silicate, titanium dioxide, hypromellose 2910 (15000 mPa.s), corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00024-1596 Sanofi
43063-0225 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.